Lifecore Biomedical Inc
LFCR
Get informed when a big investor buys or sells
+ FollowMarket Cap$170.29M
Close$
$8.68
91.2% upside
Current Fair Value
91.2% upsideUndervalued by 91.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $170.29 Million |
|---|---|
| Enterprise Value | $313.40 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.19 |
| Beta | 1.08 |
| Outstanding Shares | 37,574,538 |
Return
| Return on Equity | -167.50% |
|---|---|
| Return on Assets | -11.75% |
| Return on Invested Capital | 5.25% |
Valuation & Multiples
| P/E Ratio | -4.13 |
|---|---|
| PEG | 3.25 |
| Price to Sales | 1.51 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.53 |
| Enterprise Value to EBIT | 28.72 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.51 |
| Debt to Equity | 9.96 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$33.13 M
Average shareholder expectationNext Earnings Call
Expected Date
October 2, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$25.96 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3355▼ 44.44% |
|---|---|
| Total Calls | 61,700▲ 44.50% |
| Total Puts | 20,700▼ 37.84% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 68.04%▲ 1.03% |
|---|---|
| Total Invested | $149.47M▲ 33.10% |
| Investors Holding | 102▼ 6.00% |
ESG Score
No data
About Lifecore Biomedical Inc
796 employees
CEO: Albert Bolles Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the foo...